India's Mangalam Drugs and Organics up on expanding anti-malaria portfolio

Mangalam Drugs and Organics

20/08/2024 07:15

** Shares of Mangalam Drugs And Organics  MADR.NS  rise 6.7%
to 121.7 rupees
    ** The pharmaceutical co said on Tuesday it is expanding its
anti-malaria API portfolio with the introduction of Pyronaridine
    ** More than 226,000 shares change hands, 2.2x its 30-day
avg
    ** Stock up 24% so far this year, eyes best yearly gain
since 2020


 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))